Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura

NCT00959751 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Without Aura

Interventions

DRUG: NXN-188
DRUG: Placebo

Sponsor

NeurAxon Inc.